Emmanuelle Charpentier

Emanuelle Charpentier

Emmanuelle Charpentier is a French microbiologist, geneticist and biochemist. She is a Director at the Max Planck Institute for Infection Biology in Berlin, Honorary Professor at Humboldt University, and recipient of an Alexander von Humboldt Professorship. Prior to her current appointments, she has worked at several other institutions in Germany, Sweden, Austria, the US and France.

Prof. Charpentier’s research on a bacterial immune system contributed to  the ground-breaking CRISPR-Cas9 genome engineering technology. She has received numerous prestigious awards and distinctions, and is an elected member of several academies of sciences. She is co-founder of CRISPR Therapeutics and ERS Genomics.